地图样萎缩临床试验核心结局指标集的建立
本研究通过德尔菲法、焦点小组和访谈,纳入301名年龄相关性黄斑变性患者(多数为地图样萎缩)及专家,旨在确定地图样萎缩临床试验的核心结局指标集。最终识别出外层视网膜健康、多模式病灶大小评估、阅读速度、最佳矫正远近视力和低亮度视力、患者报告视觉表现及安全性等核心结局,建议未来试验采用该核心结局指标集。
要点
- 核心结局包括外层视网膜健康、多模式病灶大小评估和阅读速度。
- 患者报告视觉表现和安全性也被列为重要核心结局。
- 建议未来地图样萎缩试验采用该核心结局指标集。
核心结论
- 本研究确定了一套应在地图样萎缩试验中使用的核心结局指标集。
研究设计与样本
- 五部分项目包括针对患者和专家的德尔菲法、患者及家属和辅助人员的焦点小组与访谈。
- 第一轮德尔菲有301名年龄相关性黄斑变性患者参与,多数为地图样萎缩,其中183名(61%)为女性,中位(范围)年龄77(50-99)岁。
- 第二轮从第一轮301名参与者中随机选取100名,其中76名同意参加。
- 平行德尔菲专家组由非临床科学家和临床医生组成,初始轮43人,最终轮21人。
- 访谈和焦点小组包括患者(n=20)、家庭成员(n=4)和辅助人员(n=5)。
主要发现
- 对年龄相关性黄斑变性试验重要的核心结局为外层视网膜健康、多模式病灶大小评估、阅读速度、最佳矫正远近视力和低亮度视力、患者报告视觉表现及安全性。
关键数值与推荐
- 核心结局指标集包括患者报告结局测量、近视力、阅读速度和外层视网膜评估。
临床怎么用
- 未来地图样萎缩临床试验设计应采用本核心结局指标集,以统一报告患者、临床医生和研究者认为重要的结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Ongoing and recent clinical trials for geographic atrophy (GA) have used different outcomes. The goal of this study was to identify a core outcome set (COS) important for patients, clinicians and researchers, and to propose the use of COS in the design of future GA trials. METHODS: Five-component project including: Delphi method with patients and experts, focus groups and interviews with patients, relatives and workers supporting patients. Three hundred and one patients (301) with age-related macular degeneration participated in round 1 of a Delphi exercise. Most subjects had GA; 183 patients (61%) were females and the median (range) age was 77 (50-99) years. In round 2, of the 301 of the first round, 100 participants were randomly selected of whom 76 agreed to take part. In a parallel Delphi exercise, panellists comprised a mix of non-clinical scientists and clinicians (43 in the initial and 21 in the final round). In addition, interviews and focus groups consisting of patients (n=20), family members (n=4) and support workers (n=5) were undertaken. RESULTS: Core outcomes identified as important for age-related macular degeneration trials were the health of the outer retina, multimodal estimation of lesion size, reading speed, best corrected distance and near acuity, low luminance visual acuity, patient reported visual performance and safety. CONCLUSION: This study identified a set of core outcomes that should be used in GA trials. The COS include patient-reported outcome measures, near visual acuity, reading speed and assessment of the outer retina.
引用
- Krezel AK, Hogg R, Lohfeld L, et al. Core outcomes for geographic atrophy trials. Br J Ophthalmol. 2019. PMID: 31848211. doi:10.1136/bjophthalmol-2019-314949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。